• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Volcano bids for assets

Article

Laguna Hills, CA-based Volcano Therapeutics has signed a letter of intent to acquire the global intravascular ultrasound and functional measurement businesses of Jomed, a high-tech medical research company headquartered in Helsingborg, Sweden. Bankruptcy

Laguna Hills, CA-based Volcano Therapeutics has signed a letter of intent to acquire the global intravascular ultrasound and functional measurement businesses of Jomed, a high-tech medical research company headquartered in Helsingborg, Sweden. Bankruptcy is forcing Jomed to divest its assets, some of which were sold to Abbott Laboratories in June. The company plans to sell the remainder in the coming months. Volcano Therapeutics has tagged several as complementary to its efforts to develop products for the detection and treatment of atherosclerosis and vulnerable plaques in the coronary and peripheral arteries. Jomed's IVUS technology is synergistic with Volcano's Virtual Histology IVUS system, recently demonstrated at the Paris Course on Revascularization, according to Scott Huennekens, Volcano president and CEO. The California company's intravascular thermography catheter products also promise to integrate well with the pressure catheter and flow wire interventional products of Jomed's functional measurement business, he said.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.